000			01518 a2200421 4500
005			20250512053111.0
264		0	_c19880414
008			198804s 0 0 eng d
022			_a0008-543X
024	7		_a10.1002/1097-0142(19871101)60:9<2165::aid-cncr2820600908>3.0.co;2-c _2doi
040			_aNLM _beng _cNLM
100	1		_aCarr, B I
245	0	0	_aHigh doses of prochlorperazine for cisplatin-induced emesis. A prospective, random, dose-response study. _h[electronic resource]
260			_bCancer _cNov 1987
300			_a2165-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCisplatin _xadverse effects
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aProchlorperazine _xadministration & dosage
650	0	4	_aProspective Studies
650	0	4	_aRandom Allocation
700	1		_aBlayney, D W
700	1		_aGoldberg, D A
700	1		_aBraly, P
700	1		_aMetter, G E
700	1		_aDoroshow, J H
773	0		_tCancer _gvol. 60 _gno. 9 _gp. 2165-9
856	4	0	_uhttps://doi.org/10.1002/1097-0142(19871101)60:9<2165::aid-cncr2820600908>3.0.co;2-c _zAvailable from publisher's website
999			_c3445960 _d3445960